AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $4,762,000 | +100.2% | 285,000 | +72.7% | 0.51% | +54.4% |
Q1 2020 | $2,379,000 | -52.6% | 165,000 | +10.0% | 0.33% | -39.5% |
Q4 2019 | $5,021,000 | +60.7% | 150,000 | +0.5% | 0.55% | +40.3% |
Q3 2019 | $3,124,000 | +0.6% | 149,201 | 0.0% | 0.39% | +14.6% |
Q2 2019 | $3,106,000 | -6.9% | 149,201 | 0.0% | 0.34% | -12.3% |
Q1 2019 | $3,335,000 | – | 149,201 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |